ABT

neutral track record →

Two insiders buy $3.1M amid deal turmoil

Watch: Upcoming earnings call to clarify strategy on acquisition and regulatory risks could trigger stock movement.

Full analysis

Abbott Laboratories insiders Starks and Ford purchased $3.1 million of shares near $108 each, signaling confidence. The stock is down 20% YTD after a weak quarter and a lawsuit tied to baby formula issues. Abbott also announced a $21B acquisition of Exact Sciences at a 51% premium, spooking investors and pushing shares down more than $6 in two trading days.

Insider buying contrasts with heavy earlier selling, suggesting mixed confidence as Abbott invests heavily in diagnostics, facing near-term headwinds that pressure stock performance.

Compare

vs NVDA vs AMD vs AAPL vs TSLA vs MSFT vs META vs GOOGL vs AMZN vs TSM vs ASML

Evidence

1d ago Jim Cramer Says Abbot Is “Going to Have to Give Us a Couple of Reasons on the Call” to Go Higher yahoo-finance

1d ago Insider buy by STARKS DANIEL J (ABT): $1,087,331

1d ago Insider buy by FORD ROBERT B. (ABT): $2,013,967

1d ago Insider sell by EARNHARDT LISA D (ABT): $12,227,297

1d ago Insider sell by FORD ROBERT B. (ABT): $37,435,200

1d ago Insider sell by ALLEN HUBERT L. (ABT): $24,342,304

1d ago Insider sell by ALLEN HUBERT L. (ABT): $18,424,298

1d ago Insider sell by FORD ROBERT B. (ABT): $16,493,218

5 older signals

20d ago Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences

22d ago Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results

28d ago This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip?

30d ago Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India

41d ago Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval

13 signals · latest 1d ago

Get alerted when ABT changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →